XML 25 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE (Details 2) (USD $)
 3 Months Ended 212 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended
Mar. 31, 2013
Mar. 31, 2014
Nov. 14, 2013
Purchase Agreement
Aspire Capital Fund, LLC
Mar. 31, 2014
Purchase Agreement
Aspire Capital Fund, LLC
Dec. 31, 2013
Purchase Agreement
Aspire Capital Fund, LLC
Apr. 03, 2013
Definitive Agreement
Celgene Corporation
Mar. 22, 2012
Economic Rights
Apr. 30, 2013
Economic Rights
Definitive Agreement
Mar. 31, 2013
Economic Rights
Definitive Agreement
Fair value measurements                  
Number of shares issued under purchase agreement     511,509            
Purchase price for shares issued under purchase agreement     $ 2,000,000            
Shares committed to purchase     3,042,038            
Period of common stock purchase agreement     2 years            
Fair value of financial instrument     500,000 400,000 400,000        
Decrease in the fair value of the Purchase Agreement       47,000          
Amount to be paid as percentage of future litigation settlement amount received             10.00%    
One-time payment received for patent related uses           5,500,000      
Payment made to economic right holder               600,000  
Change in valuation of Economic Rights $ 570,000 $ 547,000             $ 600,000